Triple oxygen immune-induced autologous blood transfusion therapy

  What is trioxane immune-induced autologous blood transfusion therapy?  The mechanism of action of triple oxygen immune-induced autologous blood transfusion therapy is to treat various diseases and improve the functional state of the body by oxidizing, inducing and activating the metabolism and functions of the circulatory system, immune system and other tissues and organs. In particular, the pre-activation effect before radiotherapy, chemotherapy and surgery, the sensitization and protection effect during radiotherapy and chemotherapy, and the immunomodulatory effect can significantly improve the immunity and tolerance of patients, enhance the physical fitness of patients and effectively help patients to receive radiotherapy, chemotherapy and surgery smoothly, increase the efficacy of radiotherapy and chemotherapy, and reduce their side effects. Research has confirmed that trioxane can induce the body to release tumor necrosis, and tumor necrosis factor is an important factor for the body’s immune system to monitor and kill tumors.  After entering the body, trioxane reacts with body fluids to generate hydrogen peroxide: 1. It kills cancer cells and also enhances the anti-tumor function of the body.  2.Normal human cells can avoid damage by their own regulatory mechanism-producing peroxidase, while tumor cells lack the ability to produce peroxidase.  3.Super-activation effect: improve the immunity of the body, mobilize the activity of various organs and tissues of the body, so that the body is already in a state of preparation before receiving treatment, which can lay the foundation for further treatment.  4.Sensitizing effect: trioxane and hydrogen peroxide can accelerate the reoxygenation of tumor center lacking oxygen cells, thus increasing the local oxygen saturation and increasing the sensitivity of tumor to radiotherapy and chemotherapy.  Activated chemotherapy: It can enhance the treatment of leukocyte function and can reduce the application of chemotherapeutic drugs. After chemotherapy is finished, in vivo application of triple oxygen therapy can accelerate the accumulation of residual chemotherapy drugs in the body, thus reducing the toxic side effects of chemotherapy.  Activated radiotherapy: The body is hyper-activated and sensitized by radiotherapy before treatment. For radiation-sensitive tumors, the same amount of activated radiotherapy can achieve better efficacy than conventional radiotherapy; while for radiation-insensitive tumors, the hyper-activated body can tolerate more than conventional radiation. The increase in radiation dose can achieve rapid tumor load removal.  How is trioxic immuno-induced autologous blood transfusion therapy treated? Click to view the animated video: Trioxane immuno-induced autologous blood transfusion therapy for tumor treatment animation video